T o the editor: We found errors in our recently published article reporting direct and indirect meta-analyses of gabapentin vs. tricyclic antidepressants for neuropathic pain.
T o the editor: We found errors in our recently published article reporting direct and indirect meta-analyses of gabapentin vs. tricyclic antidepressants for neuropathic pain. 1 In Fig. 2 , "Favors Gabapentin" should have been placed to the right of the line indicating a relative risk of 1, and "Favors TCA" should have been placed to the left. Also, data were abstracted incorrectly from a trial by Gorson et al. 2 We based our analysis on the number of patients randomized in the first crossover period, rather than to all patients enrolled. Using the correct data for proportion that experienced pain relief (17/40 vs. 9/40) had little effect on the estimate for pain relief in placebocontrolled gabapentin trials (pooled relative risk 2.17 [95% CI 1.76 to 2.67]), and the indirect estimate and accompanying confidence intervals are unchanged. Nonetheless, we regret any confusion these errors may have caused.
